This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Eun Jung Kim: Innovator in Pharmaceutical Science
Introduction
Eun Jung Kim is a prominent inventor based in Hwaseong-si, Gyeonggi-do, South Korea. She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative drug formulations. Her work is characterized by a commitment to improving therapeutic options for patients.
Latest Patents
Eun Jung Kim holds a patent for a groundbreaking invention titled "GLP-1/GIP Dual Agonist, Long-Acting Conjugate Thereof, and Pharmaceutical Composition Comprising Same." This patent represents a significant advancement in the treatment of metabolic disorders, showcasing her expertise in drug development.
Career Highlights
Currently, Eun Jung Kim is employed at Hanmi Pharmaceutical Co., Ltd., where she continues to push the boundaries of pharmaceutical innovation. Her role at the company allows her to collaborate with other talented professionals in the industry, further enhancing her contributions to healthcare.
Collaborations
Eun Jung Kim has worked alongside notable colleagues, including Hyeon Joo Im and Nyeong Sang Yoo. These collaborations have fostered a dynamic environment for innovation and have led to the successful development of new pharmaceutical solutions.
Conclusion
Eun Jung Kim's work exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, particularly her patented inventions, are paving the way for advancements in treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile